Sensus Healthcare Inc Financials
Sensus Healthcare Inc (SRTS) reported $17.5M in revenue over the twelve months to Jun 30, 2026, down 53.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sensus's 2025 setback came from margin compression and an expanding cost base while revenue contracted, not from balance-sheet leverage.
Revenue declined34.3% in FY2025 while gross margin fell from58.4% to43.2% , indicating the downturn involved weaker unit economics rather than volume alone. Meanwhile, combined SG&A and R&D increased from$11.4M in FY2024 to$15.7M in FY2025, leaving a cost structure poorly aligned with the smaller revenue base.
Operating cash flow turned positive at
Liabilities were only
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Sensus Healthcare Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Sensus Healthcare Inc has an operating margin of -37.5%, meaning the company loses $38 on every $100 of revenue. This results in a profitability score of 15/100. This is down from 19.4% the prior year.
Sensus Healthcare Inc's revenue declined 34.3% year-over-year, from $41.8M to $27.5M. This contraction results in a growth score of 55/100.
Sensus Healthcare Inc carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 80/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 9.72, Sensus Healthcare Inc holds $9.72 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 97/100.
Sensus Healthcare Inc's free cash flow margin of 1.2% results in a low score of 24/100. Capital expenditures of $196K absorb a large share of operating cash flow.
Sensus Healthcare Inc posts a -16.1% return on equity (ROE), meaning it loses $16 for every $100 of shareholders' equity. This results in a returns score of 22/100. This is down from 11.9% the prior year.
Sensus Healthcare Inc scores 8.00, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($57.9M) relative to total liabilities ($4.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Sensus Healthcare Inc passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Sensus Healthcare Inc reported a net loss of $7.7M while generating $528K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Sensus Healthcare Inc reported an operating loss of $10.3M against $683K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Sensus Healthcare Inc generated $27.5M in revenue in fiscal year 2025. This represents a decrease of 34.3% from the prior year.
Sensus Healthcare Inc's EBITDA was -$9.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 219.5% from the prior year.
Sensus Healthcare Inc reported -$7.7M in net income in fiscal year 2025. This represents a decrease of 216.1% from the prior year.
Sensus Healthcare Inc earned -$0.47 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 214.6% from the prior year.
Cash & Balance Sheet
Sensus Healthcare Inc generated $332K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 130.0% from the prior year.
Sensus Healthcare Inc held $22.1M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Sensus Healthcare Inc's gross margin was 43.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 15.3 percentage points from the prior year.
Sensus Healthcare Inc's operating margin was -37.5% in fiscal year 2025, reflecting core business profitability. This is down 56.9 percentage points from the prior year.
Sensus Healthcare Inc's net profit margin was -28.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 44.0 percentage points from the prior year.
Sensus Healthcare Inc's ROE was -16.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 28.0 percentage points from the prior year.
Capital Allocation
Sensus Healthcare Inc invested $7.8M in research and development in fiscal year 2025. This represents an increase of 84.5% from the prior year.
Sensus Healthcare Inc spent $300K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Sensus Healthcare Inc invested $196K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 29.0% from the prior year.
SRTS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3M-32.5% | $3.4M-31.3% | $4.9M-28.3% | $6.9M-5.9% | $7.3M-12.3% | $8.3M-36.1% | $13.1M+47.8% | $8.8M |
| Cost of Revenue | $1.5M-36.7% | $2.4M-21.0% | $3.0M-27.1% | $4.2M-5.5% | $4.4M+10.6% | $4.0M-33.1% | $6.0M+65.6% | $3.6M |
| Gross Profit | $769K-22.4% | $991K-47.8% | $1.9M-30.1% | $2.7M-6.5% | $2.9M-33.3% | $4.4M-38.7% | $7.1M+35.6% | $5.2M |
| R&D Expenses | $1.1M-30.3% | $1.6M-15.5% | $1.9M+3.5% | $1.8M+23.7% | $1.5M-43.6% | $2.6M+66.9% | $1.6M+80.9% | $863K |
| SG&A Expenses | $1.8M-12.6% | $2.0M+15.9% | $1.8M-8.1% | $1.9M-3.5% | $2.0M-10.1% | $2.2M-8.6% | $2.4M+53.6% | $1.6M |
| Operating Income | -$3.2M+27.0% | -$4.4M-38.4% | -$3.1M-22.6% | -$2.6M-32.2% | -$1.9M+26.6% | -$2.6M-253.3% | $1.7M+15.5% | $1.5M |
| Interest Expense | $117K-6.4% | $125K-86.0% | $890K+456.3% | $160K+187.4% | -$183K+0.5% | -$184K+76.6% | -$788K-382.4% | $279K |
| Income Tax | $5.7M+453.8% | -$1.6M-1023.6% | $174K+111.9% | -$1.5M-102.8% | -$723K-757.3% | $110K-73.2% | $410K-26.7% | $559K |
| Net Income | -$8.7M-233.2% | -$2.6M+17.1% | -$3.2M-235.8% | -$943K+9.1% | -$1.0M+59.7% | -$2.6M-266.4% | $1.5M+27.2% | $1.2M |
| EPS (Diluted) | -$0.53-231.3% | -$0.16+15.8% | -$0.19-216.7% | -$0.060.0% | -$0.06+62.5% | -$0.16-260.0% | $0.10+42.9% | $0.07 |
SRTS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.3M-20.0% | $51.5M-2.8% | $53.0M-9.0% | $58.3M-0.9% | $58.9M-2.3% | $60.2M-3.1% | $62.2M+3.9% | $59.9M |
| Current Assets | $37.7M-11.5% | $42.6M-7.2% | $45.9M-8.6% | $50.2M-3.9% | $52.2M-3.6% | $54.2M-4.5% | $56.7M+3.5% | $54.8M |
| Cash & Equivalents | $15.2M-17.1% | $18.3M-17.0% | $22.1M-9.7% | $24.5M+10.3% | $22.2M+16.2% | $19.1M-13.5% | $22.1M-2.2% | $22.6M |
| Inventory | $18.5M+11.9% | $16.5M+13.3% | $14.6M+11.7% | $13.0M+5.1% | $12.4M+25.0% | $9.9M-1.7% | $10.1M-15.6% | $12.0M |
| Accounts Receivable | $1.7M-53.0% | $3.6M-40.8% | $6.0M-35.3% | $9.3M-26.0% | $12.6M-29.9% | $18.0M-8.7% | $19.7M+16.3% | $17.0M |
| Total Liabilities | $4.4M-26.8% | $6.0M+21.5% | $4.9M-30.4% | $7.1M+4.6% | $6.8M-5.4% | $7.2M+13.2% | $6.3M+10.7% | $5.7M |
| Current Liabilities | $4.3M-26.1% | $5.9M+24.1% | $4.7M-30.6% | $6.8M+6.1% | $6.4M-4.6% | $6.7M+14.3% | $5.9M+13.0% | $5.2M |
| Total Equity | $36.9M-19.1% | $45.5M-5.3% | $48.1M-6.0% | $51.2M-1.7% | $52.1M-1.8% | $53.0M-5.0% | $55.8M+3.1% | $54.1M |
| Retained Earnings | -$5.7M-283.2% | $3.1M-45.9% | $5.7M-35.7% | $8.9M-9.6% | $9.8M-9.5% | $10.9M-19.1% | $13.4M+13.0% | $11.9M |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
SRTS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.1M+16.5% | -$3.8M-70.0% | -$2.2M-196.2% | $2.3M-26.4% | $3.1M+216.4% | -$2.7M-223.7% | -$827K-120.9% | $4.0M |
| Capital Expenditures | $8K+166.7% | $3K-98.1% | $158K+3850.0% | $4K-85.2% | $27K+285.7% | $7K-97.6% | -$297K-11.9% | $337K |
| Free Cash Flow | -$3.1M+16.4% | -$3.8M-58.8% | -$2.4M-203.2% | $2.3M-25.9% | $3.1M+215.1% | -$2.7M-138.8% | -$1.1M-131.1% | $3.6M |
| Investing Cash Flow | -$8K-166.7% | -$3K+98.1% | -$158K-3850.0% | -$4K+85.2% | -$27K-285.7% | -$7K-102.4% | $297K+188.1% | -$337K |
| Financing Cash Flow | N/A | N/A | -$5K | $0 | $0+100.0% | -$300K-1171.4% | $28K+193.3% | -$30K |
| Share Buybacks | N/A | N/A | $0 | $0 | $0-100.0% | $300K | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
SRTS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.6%+4.4pp | 29.2%-9.2pp | 38.4%-1.0pp | 39.4%-0.3pp | 39.7%-12.5pp | 52.2%-2.2pp | 54.4%-4.9pp | 59.3% |
| Operating Margin | -138.9% | -128.4% | -63.8%-26.4pp | -37.3%-10.8pp | -26.6%+5.1pp | -31.7%-44.9pp | 13.2%-3.7pp | 16.9% |
| Net Margin | -382.1% | -77.4%-13.3pp | -64.1%-50.4pp | -13.7%+0.5pp | -14.2%+16.6pp | -30.8%-42.6pp | 11.8%-1.9pp | 13.8% |
| Return on Equity | -23.7%-18.0pp | -5.8%+0.8pp | -6.6%-4.7pp | -1.8%+0.2pp | -2.0%+2.9pp | -4.9%-7.6pp | 2.8%+0.5pp | 2.2% |
| Return on Assets | -21.2%-16.1pp | -5.1%+0.9pp | -6.0%-4.4pp | -1.6%+0.1pp | -1.8%+2.5pp | -4.3%-6.8pp | 2.5%+0.5pp | 2.0% |
| Current Ratio | 8.71+1.4x | 7.27-2.4x | 9.72+2.3x | 7.38-0.8x | 8.14+0.1x | 8.06-1.6x | 9.64-0.9x | 10.52 |
| Debt-to-Equity | 0.120.0x | 0.130.0x | 0.100.0x | 0.140.0x | 0.130.0x | 0.140.0x | 0.110.0x | 0.11 |
| FCF Margin | -137.2% | -110.7% | -47.9%-81.2pp | 33.3%-9.0pp | 42.2%+74.4pp | -32.2%-23.6pp | -8.6%-49.5pp | 40.9% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Sensus Healthcare Inc Ranks
Frequently Asked Questions
What is Sensus Healthcare Inc's annual revenue?
Sensus Healthcare Inc (SRTS) reported $27.5M in total revenue for fiscal year 2025. This represents a -34.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Sensus Healthcare Inc's revenue growing?
Sensus Healthcare Inc (SRTS) revenue declined by 34.3% year-over-year, from $41.8M to $27.5M in fiscal year 2025.
Is Sensus Healthcare Inc profitable?
No, Sensus Healthcare Inc (SRTS) reported a net income of -$7.7M in fiscal year 2025, with a net profit margin of -28.1%.
What is Sensus Healthcare Inc's EBITDA?
Sensus Healthcare Inc (SRTS) had EBITDA of -$9.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Sensus Healthcare Inc's gross margin?
Sensus Healthcare Inc (SRTS) had a gross margin of 43.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Sensus Healthcare Inc's operating margin?
Sensus Healthcare Inc (SRTS) had an operating margin of -37.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Sensus Healthcare Inc's net profit margin?
Sensus Healthcare Inc (SRTS) had a net profit margin of -28.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Sensus Healthcare Inc's return on equity (ROE)?
Sensus Healthcare Inc (SRTS) has a return on equity of -16.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Sensus Healthcare Inc's free cash flow?
Sensus Healthcare Inc (SRTS) generated $332K in free cash flow during fiscal year 2025. This represents a 130.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Sensus Healthcare Inc's operating cash flow?
Sensus Healthcare Inc (SRTS) generated $528K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Sensus Healthcare Inc's total assets?
Sensus Healthcare Inc (SRTS) had $53.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Sensus Healthcare Inc's capital expenditures?
Sensus Healthcare Inc (SRTS) invested $196K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Sensus Healthcare Inc spend on research and development?
Sensus Healthcare Inc (SRTS) invested $7.8M in research and development during fiscal year 2025.
What is Sensus Healthcare Inc's current ratio?
Sensus Healthcare Inc (SRTS) had a current ratio of 9.72 as of fiscal year 2025, which is generally considered healthy.
What is Sensus Healthcare Inc's debt-to-equity ratio?
Sensus Healthcare Inc (SRTS) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Sensus Healthcare Inc's return on assets (ROA)?
Sensus Healthcare Inc (SRTS) had a return on assets of -14.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Sensus Healthcare Inc's Altman Z-Score?
Sensus Healthcare Inc (SRTS) has an Altman Z-Score of 8.00, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Sensus Healthcare Inc's Piotroski F-Score?
Sensus Healthcare Inc (SRTS) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Sensus Healthcare Inc's earnings high quality?
Sensus Healthcare Inc (SRTS) reported a net loss of $7.7M while generating $528K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Sensus Healthcare Inc cover its interest payments?
Sensus Healthcare Inc (SRTS) reported an operating loss of $10.3M against $683K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Sensus Healthcare Inc?
Sensus Healthcare Inc (SRTS) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.